BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 28212536)

  • 21. TUBB3 Reverses Resistance to Docetaxel and Cabazitaxel in Prostate Cancer.
    Sekino Y; Han X; Kawaguchi T; Babasaki T; Goto K; Inoue S; Hayashi T; Teishima J; Shiota M; Yasui W; Matsubara A
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31412591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery of a new candidate drug to overcome cabazitaxel-resistant gene signature in castration-resistant prostate cancer by in silico screening.
    Hongo H; Kosaka T; Suzuki Y; Oya M
    Prostate Cancer Prostatic Dis; 2023 Mar; 26(1):59-66. PubMed ID: 34593983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Docetaxel/cabazitaxel and fatty acid binding protein 5 inhibitors produce synergistic inhibition of prostate cancer growth.
    Carbonetti G; Converso C; Clement T; Wang C; Trotman LC; Ojima I; Kaczocha M
    Prostate; 2020 Jan; 80(1):88-98. PubMed ID: 31661167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Taxane-induced Attenuation of the CXCR2/BCL-2 Axis Sensitizes Prostate Cancer to Platinum-based Treatment.
    Ruiz de Porras V; Wang XC; Palomero L; Marin-Aguilera M; Solé-Blanch C; Indacochea A; Jimenez N; Bystrup S; Bakht M; Conteduca V; Piulats JM; Buisan O; Suarez JF; Pardo JC; Castro E; Olmos D; Beltran H; Mellado B; Martinez-Balibrea E; Font A; Aytes A
    Eur Urol; 2021 Jun; 79(6):722-733. PubMed ID: 33153817
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of SLCO1B3 drives taxane resistance in prostate cancer.
    de Morrée ES; Böttcher R; van Soest RJ; Aghai A; de Ridder CM; Gibson AA; Mathijssen RH; Burger H; Wiemer EA; Sparreboom A; de Wit R; van Weerden WM
    Br J Cancer; 2016 Sep; 115(6):674-81. PubMed ID: 27537383
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of the stress response oncoprotein LEDGF/p75 in human cancer: a study of 21 tumor types.
    Basu A; Rojas H; Banerjee H; Cabrera IB; Perez KY; De León M; Casiano CA
    PLoS One; 2012; 7(1):e30132. PubMed ID: 22276150
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transient and stable knockdown of the integrase cofactor LEDGF/p75 reveals its role in the replication cycle of human immunodeficiency virus.
    Vandekerckhove L; Christ F; Van Maele B; De Rijck J; Gijsbers R; Van den Haute C; Witvrouw M; Debyser Z
    J Virol; 2006 Feb; 80(4):1886-96. PubMed ID: 16439544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNAs as potential therapeutics to enhance chemosensitivity in advanced prostate cancer.
    Lin HM; Nikolic I; Yang J; Castillo L; Deng N; Chan CL; Yeung NK; Dodson E; Elsworth B; Spielman C; Lee BY; Boyer Z; Simpson KJ; Daly RJ; Horvath LG; Swarbrick A
    Sci Rep; 2018 May; 8(1):7820. PubMed ID: 29777112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overexpression of claspin promotes docetaxel resistance and is associated with prostate-specific antigen recurrence in prostate cancer.
    Babasaki T; Sentani K; Sekino Y; Kobayashi G; Thang Pham Q; Katsuya N; Akabane S; Taniyama D; Hayashi T; Shiota M; Oue N; Teishima J; Matsubara A; Yasui W
    Cancer Med; 2021 Aug; 10(16):5574-5588. PubMed ID: 34240817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of the
    Lombard AP; Lou W; Armstrong CM; D'Abronzo LS; Ning S; Evans CP; Gao AC
    Mol Cancer Ther; 2021 Oct; 20(10):2061-2070. PubMed ID: 34326198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glucocorticoids Induce Stress Oncoproteins Associated with Therapy-Resistance in African American and European American Prostate Cancer Cells.
    Woods-Burnham L; Cajigas-Du Ross CK; Love A; Basu A; Sanchez-Hernandez ES; Martinez SR; Ortiz-Hernández GL; Stiel L; Durán AM; Wilson C; Montgomery S; Roy S; Casiano CA
    Sci Rep; 2018 Oct; 8(1):15063. PubMed ID: 30305646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CCR1/CCL5 interaction promotes invasion of taxane-resistant PC3 prostate cancer cells by increasing secretion of MMPs 2/9 and by activating ERK and Rac signaling.
    Kato T; Fujita Y; Nakane K; Mizutani K; Terazawa R; Ehara H; Kanimoto Y; Kojima T; Nozawa Y; Deguchi T; Ito M
    Cytokine; 2013 Oct; 64(1):251-7. PubMed ID: 23876400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A role for LEDGF/p75 in targeting HIV DNA integration.
    Ciuffi A; Llano M; Poeschla E; Hoffmann C; Leipzig J; Shinn P; Ecker JR; Bushman F
    Nat Med; 2005 Dec; 11(12):1287-9. PubMed ID: 16311605
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of rare lens epithelium-derived growth factor/p75 genetic variants identified in HIV-1 long-term nonprogressors.
    Schrijvers R; Demeulemeester J; De Rijck J; Christ F; Gérard M; Debyser Z; Gijsbers R
    AIDS; 2013 Feb; 27(4):539-43. PubMed ID: 23211777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LEDGF/p75: a novel nuclear autoantigen at the crossroads of cell survival and apoptosis.
    Ganapathy V; Daniels T; Casiano CA
    Autoimmun Rev; 2003 Sep; 2(5):290-7. PubMed ID: 12965181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination Treatment with Orlistat-Containing Nanoparticles and Taxanes Is Synergistic and Enhances Microtubule Stability in Taxane-Resistant Prostate Cancer Cells.
    Souchek JJ; Davis AL; Hill TK; Holmes MB; Qi B; Singh PK; Kridel SJ; Mohs AM
    Mol Cancer Ther; 2017 Sep; 16(9):1819-1830. PubMed ID: 28615298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Caspase cleavage of the nuclear autoantigen LEDGF/p75 abrogates its pro-survival function: implications for autoimmunity in atopic disorders.
    Wu X; Daniels T; Molinaro C; Lilly MB; Casiano CA
    Cell Death Differ; 2002 Sep; 9(9):915-25. PubMed ID: 12181742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diving Into Cabazitaxel's Mode of Action: More Than a Taxane for the Treatment of Castration-Resistant Prostate Cancer Patients.
    Mellado B; Jimenez N; Marin-Aguilera M; Reig O
    Clin Genitourin Cancer; 2016 Aug; 14(4):265-70. PubMed ID: 26827258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-181a promotes docetaxel resistance in prostate cancer cells.
    Armstrong CM; Liu C; Lou W; Lombard AP; Evans CP; Gao AC
    Prostate; 2017 Jun; 77(9):1020-1028. PubMed ID: 28485104
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Taxanes in the management of metastatic castration-resistant prostate cancer: efficacy and management of toxicity.
    Schutz FA; Buzaid AC; Sartor O
    Crit Rev Oncol Hematol; 2014 Sep; 91(3):248-56. PubMed ID: 24613528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.